ACS Publications. Most Trusted. Most Cited. Most Read

OR SEARCH CITATIONS

My Activity
Publications
CONTENT TYPES

Figure 1Loading Img
Download Hi-Res ImageDownload to MS-PowerPointCite This:J. Med. Chem. 2016, 59, 21, 9825-9836
RETURN TO ISSUEPREVArticleNEXT

Hit-to-Lead Optimization of Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists with a Diphenylmethane-Scaffold: Design, Synthesis, and Biological Study

View Author Information
† Department of Pathology, University of Pisa, 56126 Pisa, Italy
‡ Department of Pharmacy, University of Pisa, 56126, Pisa, Italy
§ Department of Neuroscience and Brain Technologies, Istituto Italiano di Tecnologia, 16163 Genova, Italy
∥ Department of NEUROFARBA, Section of Pharmacology, University of Florence, 50139 Florence, Italy
⊥ Department of Pharmacy, University of Genoa, 16126, Genoa, Italy
# Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, 199034, Russia
∇ Skolkovo Institute of Science and Technology (Skoltech), Skolkovo, Moscow Region, 143025, Russia
*For S.R.: phone, +39 050 2219582; fax, +39 050 2219577; E-mail, [email protected]
*For G.C.: phone, +39 050 2218677; E-mail, [email protected]
Cite this: J. Med. Chem. 2016, 59, 21, 9825–9836
Publication Date (Web):October 12, 2016
https://doi.org/10.1021/acs.jmedchem.6b01092
Copyright © 2016 American Chemical Society
Request reuse permissions

    Article Views

    1140

    Altmetric

    -

    Citations

    17
    LEARN ABOUT THESE METRICS
    Read OnlinePDF (2 MB)
    Get e-Alerts
    Supporting Info (2)»
    SUBJECTS:

    Abstract

    Abstract Image

    The trace amine-associated receptor 1 (TAAR1) is a G-protein-coupled receptors (GPCR) potently activated by a variety of molecules besides trace amines (TAs), including thyroid hormone-derivatives like 3-iodothyronamine (T1AM), catechol-O-methyltransferase products like 3-methoxytyramine, and amphetamine-related compounds. Accordingly, TAAR1 is considered a promising target for medicinal development. To gain more insights into TAAR1 physiological functions and validation of its therapeutic potential, we recently developed a new class of thyronamine-like derivatives. Among them compound SG2 showed high affinity and potent agonist activity at mouse TAAR1. In the present work, we describe design, synthesis, and SAR study of a new series of compounds (1–16) obtained by introducing specific structural changes at key points of our lead compound SG2 skeleton. Five of the newly synthesized compounds displayed mTAAR1 agonist activity higher than both SG2 and T1AM. Selected diphenylmethane analogues, namely 1 and 2, showed potent functional activity in in vitro and in vivo models.

    Supporting Information

    ARTICLE SECTIONS
    Jump To

    The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acs.jmedchem.6b01092.

    • Synthetic pathways and procedures for the preparation of compound 34 and derivatives 11–16, 1H NMR and 13C NMR spectra of final compounds (PDF)

    • Molecular formula strings (CSV)

    Terms & Conditions

    Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.

    Cited By

    This article is cited by 17 publications.

    1. Naoki Yasukawa, Yutaro Yamada, Chikara Furugen, Yuya Miki, Hironao Sajiki, Yoshinari Sawama. Gold-Catalyzed Tandem Oxidative Coupling Reaction between β-Ketoallenes and Electron-Rich Arenes to 2-Furylmethylarenes. Organic Letters 2021, 23 (15) , 5891-5895. https://doi.org/10.1021/acs.orglett.1c02007
    2. Masato Ohsumi and Nagatoshi Nishiwaki . Selective Synthesis of (Benzyl)biphenyls by Successive Suzuki–Miyaura Coupling of Phenylboronic Acids with 4-Bromobenzyl Acetate under Air Atmosphere. ACS Omega 2017, 2 (11) , 7767-7771. https://doi.org/10.1021/acsomega.7b01450
    3. Siyan Liao, Michael James Pino, Catherine Deleon, Maurice Lindner-Jackson, Chun Wu. Interaction analyses of hTAAR1 and mTAAR1 with antagonist EPPTB. Life Sciences 2022, 300 , 120553. https://doi.org/10.1016/j.lfs.2022.120553
    4. Valeria Francesconi, Elena Cichero, Evgeny V. Kanov, Erik Laurini, Sabrina Pricl, Raul R. Gainetdinov, Michele Tonelli. Novel 1-Amidino-4-Phenylpiperazines as Potent Agonists at Human TAAR1 Receptor: Rational Design, Synthesis, Biological Evaluation and Molecular Docking Studies. Pharmaceuticals 2020, 13 (11) , 391. https://doi.org/10.3390/ph13110391
    5. Grazia Rutigliano, Lavinia Bandini, Simona Sestito, Grazia Chiellini. 3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome?. International Journal of Molecular Sciences 2020, 21 (6) , 2005. https://doi.org/10.3390/ijms21062005
    6. Massimiliano Runfola, Simona Sestito, Lorenza Bellusci, Valeria La Pietra, Vincenzo Maria D’Amore, Marta Anna Kowalik, Grazia Chiellini, Sheraz Gul, Andrea Perra, Amedeo Columbano, Luciana Marinelli, Ettore Novellino, Simona Rapposelli. Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis. European Journal of Medicinal Chemistry 2020, 188 , 112006. https://doi.org/10.1016/j.ejmech.2019.112006
    7. Josef Köhrle, Heike Biebermann. 3-Iodothyronamine—A Thyroid Hormone Metabolite With Distinct Target Profiles and Mode of Action. Endocrine Reviews 2019, 40 (2) , 602-630. https://doi.org/10.1210/er.2018-00182
    8. Masato Ohsumi, Akitaka Ito, Nagatoshi Nishiwaki. Substrate switchable Suzuki–Miyaura coupling for benzyl ester vs. benzyl halide. RSC Advances 2018, 8 (61) , 35056-35061. https://doi.org/10.1039/C8RA07841F
    9. Elena Cichero. Opportunities and challenges in the design of selective TAAR1 agonists: an editorial. Expert Opinion on Therapeutic Patents 2018, 28 (6) , 437-440. https://doi.org/10.1080/13543776.2018.1476493
    10. Michael D. Schwartz, Juan J. Canales, Riccardo Zucchi, Stefano Espinoza, Ilya Sukhanov, Raul R. Gainetdinov. Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases. Expert Opinion on Therapeutic Targets 2018, 22 (6) , 513-526. https://doi.org/10.1080/14728222.2018.1480723
    11. Sara Guariento, Michele Tonelli, Stefano Espinoza, Andrey S. Gerasimov, Raul R. Gainetdinov, Elena Cichero. Rational design, chemical synthesis and biological evaluation of novel biguanides exploring species-specificity responsiveness of TAAR1 agonists. European Journal of Medicinal Chemistry 2018, 146 , 171-184. https://doi.org/10.1016/j.ejmech.2018.01.059
    12. Grazia Rutigliano, Alice Accorroni, Riccardo Zucchi. The Case for TAAR1 as a Modulator of Central Nervous System Function. Frontiers in Pharmacology 2018, 8 https://doi.org/10.3389/fphar.2017.00987
    13. Lorenza Bellusci, Annunziatina Laurino, Martina Sabatini, Simona Sestito, Paola Lenzi, Laura Raimondi, Simona Rapposelli, Francesca Biagioni, Francesco Fornai, Alessandra Salvetti, Leonardo Rossi, Riccardo Zucchi, Grazia Chiellini. New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection. Frontiers in Pharmacology 2017, 8 https://doi.org/10.3389/fphar.2017.00905
    14. Grazia Chiellini, Lorenza Bellusci, Martina Sabatini, Riccardo Zucchi. Thyronamines and Analogues - The Route from Rediscovery to Translational Research on Thyronergic Amines. Molecular and Cellular Endocrinology 2017, 458 , 149-155. https://doi.org/10.1016/j.mce.2017.01.002
    15. Mark D. Berry, Raul R. Gainetdinov, Marius C. Hoener, Mohammed Shahid. Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges. Pharmacology & Therapeutics 2017, 180 , 161-180. https://doi.org/10.1016/j.pharmthera.2017.07.002
    16. Elena Cichero, Michele Tonelli. Targeting species-specific trace amine-associated receptor 1 ligands: to date perspective of the rational drug design process. Future Medicinal Chemistry 2017, 9 (13) , 1507-1527. https://doi.org/10.4155/fmc-2017-0044
    17. Michele Tonelli, Stefano Espinoza, Raul R. Gainetdinov, Elena Cichero. Novel biguanide-based derivatives scouted as TAAR1 agonists: Synthesis, biological evaluation, ADME prediction and molecular docking studies. European Journal of Medicinal Chemistry 2017, 127 , 781-792. https://doi.org/10.1016/j.ejmech.2016.10.058
    Download PDF

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    MENDELEY PAIRING EXPIRED
    Your Mendeley pairing has expired. Please reconnect